about
P1196
Treatment for Barrett's oesophagusAntioxidant supplements for preventing gastrointestinal cancersAntioxidant supplements for preventing gastrointestinal cancersEpidemiology of esophageal cancerMesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.Cancer incidence in the south Asian population of California, 1988-2000.Circulating Tumor Cells in the Adenocarcinoma of the EsophagusEllagitannins in Cancer Chemoprevention and TherapyPotential biomarkers for esophageal cancerThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaAssociation between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysisAdvances in the endoscopic diagnosis and treatment of Barrett's neoplasiaGender difference in gastro-esophageal reflux diseasesEsophageal Cancer: Insights From Mouse ModelsInhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overviewAdvances in targeted therapies and new promising targets in esophageal cancerSTAT3: A Novel Molecular Mediator of Resistance to ChemoradiotherapyExtracellular matrix as an inductive scaffold for functional tissue reconstructionOptical molecular imaging in the gastrointestinal tract.Novel immunotherapeutic strategies of gastric cancer treatmentRegenerative Medicine Strategies for Esophageal RepairRapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IVEstablishment of a Non-Invasive Semi-Quantitative Bioluminescent Imaging Method for Monitoring of an Orthotopic Esophageal Cancer Mouse ModelCorrelation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis.The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.Interventional Therapy of Esophageal CancerTranslational research in thoracic surgery-the National Taiwan University Hospital experienceAdvances in the Endoscopic Diagnosis of Barrett EsophagusEffects of neutrophil elastase inhibitor in patients undergoing esophagectomy: a systematic review and meta-analysisShear stress modulates the interaction of platelet-secreted matrix proteins with tumor cells through the integrin alphavbeta3Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancersAberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancerPITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinomaAlcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkersA review of pterostilbene antioxidant activity and disease modificationIncreased risk of oesophageal adenocarcinoma among upstream petroleum workersNo evidence of HPV DNA in esophageal squamous cell carcinoma in a population of Southern BrazilInteractions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinomaTumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma
P2860
Q24240701-B04820BA-5C7E-43F8-877A-0BFAC5325566Q24242191-37F818B8-31F1-4D9D-9FF3-DDED577B1A46Q24245704-059EF804-2F10-4B0C-BF6E-1AC5BA411A6DQ24625927-225ED942-A722-448F-909D-39172CAB380DQ24642374-ECDA2CAC-5B59-4CD3-AB92-B676CC02F034Q24812191-D2D27A89-7416-4D85-B292-400DD67730F8Q26741429-9DD73C1B-7FA9-4ECD-BE59-2E5651C24426Q26748955-C3595075-5BE7-4E2A-976C-40F879508821Q26749416-AD9423DA-0DD5-4136-954B-EA89A75AC98EQ26750641-25920809-734E-4EE4-A0EE-6E4FF078B42DQ26765762-09A6DEB2-0B61-4FF6-8E14-4CAB02E3758FQ26766113-2DE057C2-8FDF-4AAB-823F-1E2FB45F364CQ26768413-04F87E2F-C2D5-447B-B20E-9808A27BD23EQ26783904-E08E0B86-1973-4E1D-A544-F66BDCE03BDFQ26822792-C13CDAFE-7500-4A70-84E9-BFF3F6213629Q26825957-9F83CA2C-5EA4-48FF-A643-E42DDB5A85C4Q27003190-F6A7F3FB-D882-4C84-B11F-D7ABFE87D8DEQ27006822-EB1C8F7C-2ABB-45D2-AE3E-601E9D35FBC2Q27008366-C4E28026-2046-4DD7-B74A-2B35C675333BQ27011232-DA4F8282-2613-45D8-ACC1-B84DB13681A7Q27027551-0D581915-CA57-44BE-A189-07CC9DD62D53Q27313528-D6ECCA1A-8940-4D4F-9AB4-53F040698926Q27321510-4E04075A-6272-45C6-8E92-F100E2FF6733Q27852124-D0659C74-E8DA-42E9-8C0D-69DDE82A1567Q27853383-F4FEA044-3118-4977-BE58-6D3819BD4823Q28072495-48C100A7-F92D-4FFD-86B7-0D6B4D13F78EQ28073690-D09FD255-91F1-4579-B278-31E9229067ABQ28073879-F59A2698-4406-4CA0-9C5C-FF16A73AF533Q28083777-705B89AA-3651-408E-950D-2DCBB9BC3E5EQ28198969-8685C487-EFE2-4D71-BB2C-83FEF612BB64Q28218710-DCA4378B-556A-4EC6-8D9F-5A19240AF7F7Q28240796-2B119850-6810-46EA-BE87-9222DA502180Q28278786-A2B4AC53-D748-45E5-965D-932864FE74B0Q28281742-BB337EFA-8021-4BEB-9F6C-8B6B5FA93BA5Q28291048-30177C86-AE8B-46C0-80CB-8AFA90F5CE58Q28386571-0286C763-9836-489B-9C70-FACCD3E3DCE0Q28389967-96D49BAA-C5F1-4D34-A844-A7E7F7DDE681Q28396031-AFA7001B-AF01-4699-9C5D-8A3DD57CEC03Q28478733-CB009C6B-18E9-42F9-A465-9D995E8C191FQ28550965-B89942E7-4E96-4EAA-8EE3-31A291B3D5AA
P2860
description
im Dezember 2003 veröffentlichter wissenschaftlicher Artikel
@de
scholarly article
@en
наукова стаття, опублікована в грудні 2003
@uk
name
Esophageal Cancer
@en
type
label
Esophageal Cancer
@en
prefLabel
Esophageal Cancer
@en
P356
P1476
Esophageal Cancer
@en
P2093
Peter C. Enzinger
Robert J. Mayer
P304
P356
10.1056/NEJMRA035010
P407
P577
2003-12-04T00:00:00Z